New Weight-Loss Drug Beats Ozempic in Early Mouse Studies

German researchers have developed a breakthrough drug that outperformed popular weight-loss medications in early tests, targeting five body systems at once.

The "quintuple agonist" could mean better results with fewer side effects, though human trials are still needed.